JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Mohamed F. Ibrahim
Domenico Paparella
Stephanie J. Brister
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ibrahim, M. F.
Right arrow Articles by Brister, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibrahim, M. F.
Right arrow Articles by Brister, S. J.
Related Collections
Right arrow Valve disease

J Thorac Cardiovasc Surg 2003;126:959-964
© 2003 The American Association for Thoracic Surgery


Surgery for acquired cardiovascular disease

Gender-related differences in morbidity and mortality during combined valve and coronary surgery

Mohamed F. Ibrahim, FRCS(C-Th)a, Domenico Paparella, MDa, Joan Ivanov, PhDa, Michael R. Buchanan, PhDb, Stephanie J. Brister, MDa,*

a Division of Cardiovascular Surgery of Toronto General Hospital and University of Toronto, Toronto, Ontario, Canada
b Department of Pathology and Molecular Medicine, McMaster University Health Sciences Centre, Hamilton, Ontario, Canada

Received for publication December 10, 2001; revisions received January 23, 2002; accepted for publication November 25, 2002.

* Address for reprints: Stephanie J. Brister, MD, Toronto General Hospital, University Health Network, 200 Elizabeth St, 14 Eaton North, Room 214, Toronto, Ontario M5G 2C4, Canada
stephanie.brister{at}uhn.on.ca

BACKGROUND:: Gender-related differences in morbidity and mortality are well described for coronary artery bypass grafting but are not well understood for combined valve and bypass surgery.

METHODS: We reviewed retrospectively the morbidity and mortality of 1570 consecutive patients who underwent combined valve and bypass procedures at the Toronto General Hospital between January 1990 and October 2000.

RESULTS: There were 1073 men (68%) and 497 women (32%). The mean ages (± 1 SD) of women and men were 69 ± 9 and 68 ± 9 years, respectively (P = .02). Of the 1570 total patients, 973 patients (62%) underwent aortic valve and coronary bypass surgery , 481 patients (31%) had mitral valve and coronary bypass operations, and 116 (7%) patients had double or triple valve and coronary bypass operations. Preoperative hypertension (P = .002), diabetes (P = .001), and atrial fibrillation (P = .001) were seen more frequently in women. Body surface area was significantly lower in women (P = .0001). At presentation, more women were in congestive heart failure (69% vs 58%, P = .001) and in New York Heart Association functional class III or IV (25% vs 19%, P = .001). Although there was no difference in the number of women with three or more diseased vessels (32% vs 38%), only 35% of women received three or more grafts compared with 44% of men (P = .001). The use of left internal thoracic grafts, although uncommon in the whole study population (36%), was less common in women than in men (26% vs 41%, P = .001). Multivariable logistic analyses for morbidity and mortality showed female gender to be an independent risk factor. Mitral valve replacement, age, left ventricular dysfunction, New York Heart Association classes III and IV, and association of tricuspid valve disease, diabetes, peripheral vascular disease, and preoperative renal failure were found to be independent risk factors for mortality.

CONCLUSION: Female gender is an independent risk factor for combined morbidity and mortality during and after combined valve and coronary bypass surgery. As with isolated coronary artery bypass grafting, women undergoing combined procedures have more premorbid conditions, are more often in heart failure, had an equal incidence of triple vessel disease but received fewer grafts than men, and, therefore, were more frequently incompletely revascularized.





This article has been cited by other articles:


Home page
Anesth. Analg.Home page
C. G. Koch
Con: Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management
Anesth. Analg., July 1, 2008; 107(1): 33 - 36.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Matyal
Newly Appreciated Pathophysiology of Ischemic Heart Disease in Women Mandates Changes in Perioperative Management: A Core Review
Anesth. Analg., July 1, 2008; 107(1): 37 - 50.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. M. Fedoruk, H. Wang, M. R. Conaway, I. L. Kron, and K. C. Johnston
Statin therapy improves outcomes after valvular heart surgery.
Ann. Thorac. Surg., May 1, 2008; 85(5): 1521 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. Parolari, L. Dainese, M. Naliato, G. Polvani, C. Loardi, M. Trezzi, M. Fusari, C. Beverini, E. Tremoli, P. Biglioli, et al.
Do Women Currently Receive the Same Standard of Care in Coronary Artery Bypass Graft Procedures as Men? A Propensity Analysis
Ann. Thorac. Surg., March 1, 2008; 85(3): 885 - 890.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. L. Lazar, T. Keilani, C. A. Fitzgerald, O. M. Shapira, C. T. Hunter, R. J. Shemin, H. C. Marsh Jr, U. S. Ryan, and the TP10 Cardiac Surgery Study Group
Beneficial Effects of Complement Inhibition With Soluble Complement Receptor 1 (TP10) During Cardiac Surgery: Is There a Gender Difference?
Circulation, September 11, 2007; 116(11_suppl): I-83 - I-88.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. D. Etz, T. M. Homann, N. Rane, C. A. Bodian, G. Di Luozzo, K. A. Plestis, D. Spielvogel, and R. B. Griepp
Aortic root reconstruction with a bioprosthetic valved conduit: A consecutive series of 275 procedures
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1455 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. I. Duncan, J. Lin, C. G. Koch, A. M. Gillinov, M. Xu, and N. J. Starr
The Impact of Gender on In-Hospital Mortality and Morbidity After Isolated Aortic Valve Replacement
Anesth. Analg., October 1, 2006; 103(4): 800 - 808.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Doenst, J. Ivanov, M. A. Borger, T. E. David, and S. J. Brister
Sex-specific long-term outcomes after combined valve and coronary artery surgery.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1632 - 1636.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. E. Falcoz, S. Chocron, F. Laluc, M. Puyraveau, D. Kaili, M. Mercier, and J. P. Etievent
Gender analysis after elective open heart surgery: a two-year comparative study of quality of life.
Ann. Thorac. Surg., May 1, 2006; 81(5): 1637 - 1643.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. A. Fox and N. A. Nussmeier
Does Gender Influence the Likelihood or Types of Complications Following Cardiac Surgery?
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 283 - 295.
[Abstract] [PDF]


Home page
CirculationHome page
H. L. Lazar, P. M. Bokesch, F. van Lenta, C. Fitzgerald, C. Emmett, H. C. Marsh Jr, U. Ryan, and OBE and the TP10 Cardiac Surgery Study Group
Soluble Human Complement Receptor 1 Limits Ischemic Damage in Cardiac Surgery Patients at High Risk Requiring Cardiopulmonary Bypass
Circulation, September 14, 2004; 110(11_suppl_1): II-274 - II-279.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The American Association for Thoracic Surgery.